HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU import tax

This article was originally published in The Rose Sheet

Executive Summary

Public notice of the United States Trade Representative's definitive list of retaliatory 100% ad valorem tariff measures on a variety of consumer products imported from the European Union has been delayed. The U.S. is considering placing a tax on certain products imported from the EU, including a number of bath products, if the Union fails to implement World Trade Organization recommendations on bananas ("The Rose Sheet" Dec. 7, p. 4). In a Dec. 15 statement, European Commission VP Leon Brittan, representing the EU, urged the U.S. not to publish the list, stating that such a course would "be further evidence of an unwillingness to pursue the agreed multilateral dispute settlement process." Brittan implored the U.S. "to turn away from unnecessary confrontation when we are both faced with wider and more important challenges." The list is now scheduled to be made public the week of Dec. 21

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006134

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel